Microcirculation as a novel marker of membrane biocompatibility

International Journal of Artificial Organs

Volumn 29, Issue 12, 2006, Pages 1117-1120

  Teatini, Ugo ^a   Ballerini, L ^b   Romei Longhena, G ^a   Savino, R ^a   Maltagliati, L ^a   Masi, F ^a   Colombo, R ^a   Cimino, R ^a   Manfred, I A ^a  

^a Bollate Hospital   (Italy)

^b Renal Division   (Italy)

Author keywords

Arterial PaO2; Biocompatibility; Hemodialysis; Membrane

Indexed keywords

MEMBRANES; PATIENT TREATMENT;

ARTERIAL BLOOD; ARTERIAL PAO2; BIOLOGICAL EFFECTS; BIOLOGICAL REACTION; BLOOD GAS; CLINICAL MEASURE; HAEMODIALYSIS; SYNTHETIC MEMBRANES;

BIOCOMPATIBILITY;

CARBON DIOXIDE; ETHYLENE VINYL ALCOHOL COPOLYMER; OXYGEN; POLYSULFONE;

ADULT; ARTERIAL GAS; ARTICLE; BIOCOMPATIBILITY; CARBON DIOXIDE TENSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIALYSIS MEMBRANE; FEMALE; HEMODIALYSIS; HUMAN; HYPOTHESIS; LONG TERM CARE; MALE; MATERIALS TESTING; MICROCIRCULATION; OXYGEN TENSION; PRESCRIPTION; TRANSCUTANEOUS OXYGEN MONITORING;

EID: 33846481297     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880602901204     Document Type: Article

References (13)

1. Ward RA, McLeish KR. Oxidant stress in hemodialysis patients: what are the determining factors? Int J Artif Organs 2003; 27: 230-6.
2. Lonneman G, Haubitz M, Schindler R. Hemodialysis-associated induction of cytokines. Blood Purif 1990; 8: 214-22.
3. Pereira B. Cytokine production in patients on dialysis. Blood Purif 1995; 13: 135-46.
4. Lindhout T. Biocompatibility of extracorporeal blood treatment-selection of haemostatic parameters. Nephrol Dial Transplant 1994; 9: 83-5.
5. Hofbauer R, Moser D, Frass M et al. Effect of anticoagulation on blood membrane interaction during hemodialysis. Kidney Int 1999; 56: 1578-83.
6. Franck RD, Weber J, Dresbach H, Thelen H, Weiss C, Floege J. Role of contact system activation in hemodialyzer induced thrombogenicity. Kidney Int 2001; 60: 1972-81.
7. Tetta C, David S, Mariano F, Denitti C, Panichi V. Alterations of the cytokine network in hemodialysis. J Nephrol 2001; 14 (suppl 4): S22-9.
8. Hauser CJ, Shoemaker WC. Use of a transcutaneous PO2 regional perfusion index to quantify tissue perfusion in peripheral vascular disease. Ann Surg 1983; 197: 337-43.
9. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003; 18: 1272-80.
10. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 2000; 102: 2636-42.
11. Stenvinkel P. Anemia and inflammation: what are the implication for the nephrologist? Nephrol Dial Transplant 2003; 18: 17-22.
12. Naito H, Miyazaki T, Obata S et al. Analytical study of protein deposits on the inner surface of EVAL hollow fiber membrane in non anticoagulant hemodialysis. Int J Artif Organs 1983; 12: 642-5.
13. Itadani T. Kidney and Dialysis. Special Issue 2003; 55: 112-5.